Parasitology

The Department of Parasitology conducts research on human infections caused by parasites, and the relationship between parasitic infections and other diseases.

This is what we stand for

This short movie highlights our activities and what we stand for as Department of Parasitology.

Genetically-attenuated malaria parasite vaccine

The department has developed genetically attenuated malaria parasites (GAP) as a vaccine against malaria. Clinical trials are currently ongoing.

Controlled human infections 

Clinical studies in which healthy volunteers are infected with micro-organisms under highly controlled conditions are extremely important to develop novel medicine and vaccines. For this reason trial participants at the LUMC are exposed to schistosome worms and hookworm larvae. 

A World Without Asthma

'A World Without Asthma' (AWWA) is an international consortium for the prevention of childhood asthma in the Netherlands Lung Foundation | Accelarate program. We will translate beneficial influences of commensals into a preventive strategy for asthma, aiming at a large group of children.

HelP-T2D (Helminth Products for Type 2 Diabetes)

HelP-T2D is a ZonMW-funded pre-clinical project aimed to investigate the beneficial effects of helminth-derived molecules in the context of metabolic disorders, such as obesity, insulin resistance and  type 2 diabetes.

FreeBILy

FreeBILy is an EDCTP-funded project for improvement of the health of pregnant women, newborns and infants in developing countries. Implementation of our rapid diagnostic test for schistosomiasis in Madagaskar and Gabon is an important goal of the project.

DTECT-Schisto (eng)

DTECT-Schisto aims to develop a new antibody test for diagnosing schistosomiasis in blood or urine. The project brings together researchers from the Department of Parasitology (LUMC) and Nagasaki University (NEKKEN) in partnership with Lygature (Utrecht). The project is funded by the GHIT Fund.

Current events

Stay informed about our latest news? Subscribe to the LUMC newsletter.